Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments ...

Inhibiting the herpes simplex virus type 1 viral enzyme uracil-DNA glycosylase reactivates the natural defense protein apolipoprotein B mRNA editing enzyme, catalytic polypeptide-1 (APOBEC1) in the ...

This is read by an automated voice. Please report any issues or inconsistencies here. Cancer-fighting, genetically engineered herpes simplex virus has been shown to be an effective treatment for ...

For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...

Herpes has been called “the gift that keeps on giving” — finally, its presence has come in handy. Roughly two-thirds of the global population has been infected with herpes simplex virus type 1 (HSV-1) ...

For many years, scientists have known that the herpes simplex virus-1 (HSV-1), which causes cold sores, can take up residence in parts of neurons in the peripheral nervous system. Stress can even ...